Hospital Microbiology Testing Market - Global Industry Analysis 2016 - 2024

Clinical microbiology plays an important role in an individual’s health and helps to manage infectious disease outbreak by identifying pathogens having potential to infect people. Hospital microbiology testing is a part of clinical laboratory testing involved in conducting multiple tests and blood collections in hospitals. It enables adequate management of threats of infectious diseases. Timeliness of diagnosis, appropriateness of treatment, advances in infectious disease practices and training of future practitioners are some of the factors driving the global hospital microbiology testing market.

Maintaining high quality microbiological laboratories in hospitals is currently the best approach for management of emerging infectious diseases. Intense focus on controlling healthcare expenditure has led to important changes in managing various infectious diseases. Additionally, hospital based microbiology testing enables effective communication between the physician and microbiology laboratory is other important aspect of on-site microbiology testing. Also, training future healthcare practitioners in hospitals is made easy due to ready access to microbiology laboratory. Such trainings are bound to get hampered in cases where microbiology testing laboratories are at distant location from hospitals.

Download exclusive Sample of this report:
http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=4065

Hospital Microbiology Testing Market: Segmentation

The global hospital microbiology testing market can be segmented based on disease type tests for AIDS, antrax, babesiosis, Candida, Adenovirus, Chancroid, chagas disease, Campylobacter, Brucella, Blastocystis hominis, Chlamydia, Cytomegalovirus, Clostridium difficile, Coxsackieviruses, Creutzfeldt-Jakob's disease, Coronaviruses, Cyclospora cayetanensis, E. Coli, Ebola Virus, EchoVirus, Enteroviruses, Encephalitis, Epstein-Barr virus, Gonorrhea, Giardia lamblia, West Nile Virus, Tuberculosis, Trichomonas vaginalis, Toxoplasmosis, Syphilis, Streptococci, Staphylococcus aureus and various others.

The market is also segmented based on the diagnostic technologies used in global hospital microbiology testing market. The diagnostic technologies include molecular diagnostics, monoclonal antibodies, immunoassays, differential light scattering, liposome, flow cytometry, chromatography, gel microdroplets and others. Geographically, the global hospital microbiology testing market is segmented into four major regions namely, North America, Europe, Asia-Pacific and Rest of the World.

Browse the Market Research Report
http://www.transparencymarketresearch.com/hospital-microbiology-testing-market.html

Hospital Microbiology Testing Market: Trends and Drivers

Hospital microbiology testing overcomes the drawback of the important aspects such as specimen handling and transport. Delay in transportation of the specimen in distant laboratories not only impacts the testing but also the integrity of the specimen. This may lead to a false positive or false negative result of analysis which can be life threatening. Few examples which show broad variety of specimen samples are affected by delay in transport or testing include overgrowth of Shigella species or death of meningococci in cerebrospinal fluid if not cultured rapidly which in many cases may lead to false negative results.

Thus these issues are better addressed by inoculating specimens the hospitals itself and then transported to centralized laboratories if required. This initial process dictates the need of technologists and expertise in clinical microbiology and not generalist since initial processing of microbiology samples is critical.

In addition, reductions in reimbursement provided by governmental healthcare providers have led most of the hospitals and medical centers to undertake enhancement of their microbiological laboratory capabilities. It has also been suggested that hospital based microbiology laboratories should be offered easily obtainable annual grants depending on the hospital size and criticality of care.

With growing attention focused on increase in infectious diseases and improved quality of healthcare outcomes, it appears that managing of infectious disease can be best accomplished by maintaining microbiological testing laboratories on the same site i.e. in hospitals to promote good patient care outcomes and also to save money. Thus the goal of hospital microbiology testing includes achievement of excellence in patient care, affordable diagnosis and treatment and high quality outcome. Some of the key players contributing to the microbiology testing market include Abbott Diagnostics, Affymetrix, bioMerieux, Cepheid, Hologic, Ortho-Clinical Diagnostics, Qiagen, Roche Diagnostics, Siemens and Thermo Fischer Scientific.

Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.

90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com

This release was published on openPR.